- Home
- MACI vs DMAC Comparison
MACI vs DMAC Comparison
Compare MACI & DMAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MACI
- DMAC
- Stock Information
- Founded
- MACI 2024
- DMAC 2000
- Country
- MACI United States
- DMAC United States
- Employees
- MACI N/A
- DMAC N/A
- Industry
- MACI
- DMAC Biotechnology: Pharmaceutical Preparations
- Sector
- MACI
- DMAC Health Care
- Exchange
- MACI NYSE
- DMAC Nasdaq
- Market Cap
- MACI 218.2M
- DMAC 224.6M
- IPO Year
- MACI 2024
- DMAC N/A
- Fundamental
- Price
- MACI $10.12
- DMAC $5.80
- Analyst Decision
- MACI
- DMAC Strong Buy
- Analyst Count
- MACI 0
- DMAC 3
- Target Price
- MACI N/A
- DMAC $7.00
- AVG Volume (30 Days)
- MACI 19.2K
- DMAC 100.7K
- Earning Date
- MACI 01-01-0001
- DMAC 03-18-2025
- Dividend Yield
- MACI N/A
- DMAC N/A
- EPS Growth
- MACI N/A
- DMAC N/A
- EPS
- MACI N/A
- DMAC N/A
- Revenue
- MACI N/A
- DMAC N/A
- Revenue This Year
- MACI N/A
- DMAC N/A
- Revenue Next Year
- MACI N/A
- DMAC N/A
- P/E Ratio
- MACI N/A
- DMAC N/A
- Revenue Growth
- MACI N/A
- DMAC N/A
- 52 Week Low
- MACI $9.95
- DMAC $2.14
- 52 Week High
- MACI $10.18
- DMAC $6.41
- Technical
- Relative Strength Index (RSI)
- MACI N/A
- DMAC 58.22
- Support Level
- MACI N/A
- DMAC $5.25
- Resistance Level
- MACI N/A
- DMAC $5.85
- Average True Range (ATR)
- MACI 0.00
- DMAC 0.39
- MACD
- MACI 0.00
- DMAC 0.01
- Stochastic Oscillator
- MACI 0.00
- DMAC 73.02
About MACI MELAR ACQUISITION CORP. I
Melar Acquisition Corp I is a blank check company.
About DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is principally engaged in the business activity of developing treatments for unmet clinical needs or where no therapies are available with a primary focus on chronic kidney disease and acute ischemicstroke. Its pipeline product DM199 is a recombinant form of human tissue kallikrein-1.